Κυριακή 15 Μαΐου 2016

[Multidisciplinary team meetings settings on the management of women at high risk of inherited breast cancer. A French study].

[Multidisciplinary team meetings settings on the management of women at high risk of inherited breast cancer. A French study].

Bull Cancer. 2016 May 10;

Authors: Gillmann F, Cordier C, Taris N, Mathelin C, Maugard CM

Abstract
INTRODUCTION: In France, 126 centers for cancer genetics coordinate genetic testing and high-risk cancer surveillance for individuals and their families with hereditary cancer syndromes. Since 2012, the French National Cancer Institute (INCa) supports 17 projects to promote and manage the monitoring of individuals genetically predisposed to cancer. They were assigned 4 missions by INCa including expertise for difficult cases.
METHODS: We initiated a national survey to assess how the oncogenetic clinics responded to the 4th mission for women at high risk of developing breast cancers. We sent the survey to all the French oncogeneticists. We aimed at evaluating the modalities and the extent of implementation of the Multidisciplinary team (MDT) meetings regarding the management of women who have genetically higher risks to develop breast cancer.
RESULTS: Fourteen people from 12 administrative regions, who represent 10 of the 17 projects, answered the form. Eleven participants reported the submission of medical cases in Oncogenetics MDT meetings (79 %), 5 in senology MDT meetings (36 %), 5 in MDT meetings dedicated to patients at high risk for breast cancer (36 %) and 2 in network meetings (14 %). Some structures discuss medical cases through different MDT meetings.
CONCLUSION: Although MDT meetings are valuable practices to optimize treatment or management options for patients, its settings might be subject to difficulties to federate the appropriate-number of participants as well as cost-effectiveness issues. This survey thus suggests the need of a standardized process of MDT meetings while taking account specificities of oncogenetics.

PMID: 27178881 [PubMed - as supplied by publisher]



from Cancer via ola Kala on Inoreader http://ift.tt/1WyXhNn
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου